ResearcherMicrobial Chemistry Research FoundationActive in the last 2 years
Daisuke Tatsuda
Matched on OpenAlex author ID A5066124396. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 4
- SUSD2 Promotes Metastasis and Primary Tumor Growth in Pancreatic Cancer Cells via Integrin-FAK Signaling Activation. Co-author DOI 10.1111/cas.70318↗
- New oligomycin derivatives inhibit anchorage-independent growth of pancreatic cancer cells. Co-author DOI 10.1038/s41429-025-00832-9↗
- Two new adenopeptins B and C inhibit sphere formation of pancreatic cancer cells. Co-author DOI 10.1038/s41429-023-00679-y↗
- Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic Cancer Cells. Co-author DOI 10.21873/anticanres.16415↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Junjiro Yoshida · 4 shared papers, 2023–2026 · strength 1.00
- Paper SUSD2 Promotes Metastasis and Primary Tumor Growth in Pancreatic Cancer Cells via Integrin-FAK Signaling Activation. DOI 10.1111/cas.70318↗
- Paper Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic… DOI 10.21873/anticanres.16415↗
- Paper New oligomycin derivatives inhibit anchorage-independent growth of pancreatic cancer cells. DOI 10.1038/s41429-025-00832-9↗
- Manabu Kawada · 4 shared papers, 2023–2026 · strength 1.00
- Paper SUSD2 Promotes Metastasis and Primary Tumor Growth in Pancreatic Cancer Cells via Integrin-FAK Signaling Activation. DOI 10.1111/cas.70318↗
- Paper Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic… DOI 10.21873/anticanres.16415↗
- Paper New oligomycin derivatives inhibit anchorage-independent growth of pancreatic cancer cells. DOI 10.1038/s41429-025-00832-9↗
- Isao Momose · 1 shared paper, 2026 · strength 0.27
- Atsushi Masamune · 1 shared paper, 2026 · strength 0.27
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.